Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 12, 2012, Pages

  Sheikh, Aziz ^a   Simons, F Estelle R ^b   Barbour, Victoria ^c   Worth, Allison ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT;

ANAPHYLAXIS; DRUG SELF ADMINISTRATION; HUMAN; INSTRUMENTATION; INTRAMUSCULAR DRUG ADMINISTRATION; REVIEW;

ADRENERGIC AGONISTS; ANAPHYLAXIS; EPINEPHRINE; HUMANS; INJECTIONS, INTRAMUSCULAR; SELF ADMINISTRATION;

EID: 84866774507     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008935.pub2     Document Type: Review

References (71)

1. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 2007;62:838-41. [MEDLINE: 17620061]
2. Arkwright PD, Farragher AJ. Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic children. Pediatric Allergy and Immunology 2006;17:227-9. [MEDLINE: 16672012]
3. Arkwright PD. Automatic epinephrine device use in children with food allergies. Journal of Allergy and Clinical Immunology 2009;123:267-8. [MEDLINE: 18845329]
4. Ben-Shoshan M, Kagan R, Primeau MN, Alizadehfar R, Verreault N, Yu JW, et al. Availability of the epinephrine autoinjector at school in children with peanut allergy. Annals of Allergy, Asthma, and Immunology 2008;100:570-5. [MEDLINE: 18592821]
5. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. Journal of Allergy and Clinical Immunology 2007;119:1016-8. [MEDLINE: 17306354]
6. Brown SG. Clinical features and grading of anaphylaxis. Journal of Allergy and Clinical Immunology 2004;114:371-6. [MEDLINE: 15316518]
7. Brown SGA, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Medical Journal of Australia 2006;185:283-9. [MEDLINE: 16948628]
8. Campbell RL, Hagan JB, Li JTC, Vukov SC, Kanthala AR, Smith VD, et al. Anaphylaxis in emergency department patients 50 or 65 years or older. Annals of Allergy, Asthma, and Immunology 2011;106:401-6. [MEDLINE: 21530872]
9. Confino-Cohen R, Goldberg A. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study. Annals of Allergy, Asthma, and Immunology 2010;104:73-8. [MEDLINE: 20143649]
10. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. Journal of Allergy and Clinical Immunology 2008;122:1161-5. [MEDLINE: 18992928]
11. Edwards E, Gunn R, Simons FER, Carr K, Chinchilli VM, Painter G, et al. Epinephrine 0.3 mg bioavailability following a single injection with a novel epinephrine auto-injector, e-cue, in healthy adults, with reference to a single injection using EpiPen 0.3 mg. Submitted for 2012 AAAAI Annual Meeting.
12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. [MEDLINE: 9310563]
13. Flokstra-de Blok BMJ, Doriene van Ginkel C, Roerdink EM, Kroeze MAJM, Stel AA, van der Meulen GN, et al. Extremely low prevalence of epinephrine autoinjectors in high-risk food-allergic adolescents in Dutch high schools. Pediatric Allergy and Immunology 2011;22:374-7. [MEDLINE: 21535178]
14. Frew AJ. What are the ‘ideal’ features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis?. Allergy 2011;66:15-24. [MEDLINE: 20716315]
15. Gallagher M, Worth A, Cunningham-Burley S, Sheikh A. Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK. Clinical and Experimental Allergy 2011;41:869-77. [MEDLINE: 21481022]
16. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Annals of Allergy, Asthma, and Immunology 2007;98:252-7. [MEDLINE: 17378256]
17. Greenhawt MJ, Singer AM, Baptist AP. Food allergy and food allergy attitudes among college students. Journal of Allergy and Clinical Immunology 2009;124:323-7. [MEDLINE: 19560802]
18. Guerlain S, Wang L, Hugine A. Intelliject’s novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with Epipen and Twinject. Annals of Allergy, Asthma, and Immunology 2010;105:480-4. [MEDLINE: 21130387]
19. Guerlain S, Hugine A, Wang L. A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference. Annals of Allergy, Asthma, and Immunology 2010;104:172-7. [MEDLINE: 20306821]
20. Hellstrom A, Eriksson K, Efraimsson EO, Svedmyr J, Borres MP. Assessment of self-administered epinephrine during a training session. Acta Paediatrica 2011;100:e34–5. [MEDLINE: 21635360]
21. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58. [MEDLINE: 12111919]
22. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
23. Huang SW. A survey of EpiPen use in patients with a history of anaphylaxis. Journal of Allergy and Clinical Immunology 1998;102:525-6. [MEDLINE: 9768598]
24. Jarvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. Journal of Allergy and Clinical Immunology 2008;122:133-8. [MEDLINE: 18547626]
25. Jarvinen KM, Amalanayagam S, Shreffler WG, Noone S, Sicherer SH, Sampson HA, et al. Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children. Journal of Allergy and Clinical Immunology 2009;124:1267-72. [MEDLINE: 20004784]
26. Kemp SF, Lockey RF, Simons FER. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63:1061-70. [MEDLINE: 18828525]
27. Korenblat P, Lundie MJ, Dankner RE, Day JH. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?. Allergy and Asthma Proceedings 1999;20:383-6. [MEDLINE: 10624495]
28. Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000;106:762-6. [MEDLINE: 11015520]
29. Lieberman P. Biphasic anaphylactic reactions. Annals of Allergy, Asthma, and Immunology 2005;95:217-26. [MEDLINE: 15753908]
30. Lieberman P, Camargo CA Jr, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Annals of Allergy, Asthma, and Immunology 2006;97:596-602. [MEDLINE: 17165265]
31. Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. Journal of Allergy and Clinical Immunology 2010;126:477-80. [MEDLINE: 20692689]
32. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Annals of Allergy, Asthma, and Immunology 2008;101:387-93. [MEDLINE: 18939727]
33. Manivannan V, Campbell RL, Bellolio F, Stead LG, Li JTC, Decker WW. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Annals of Allergy, Asthma, and Immunology 2009;103:395-400. [MEDLINE: 19927537]
34. Mehr S, Robinson M, Tang M. Doctor--how do I use my EpiPen?. Pediatric Allergy and Immunology 2007;18:448-52. [MEDLINE: 17617813]
35. Mehr S, Liew WK, Tey D, Tang MLK. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clinical and Experimental Allergy 2009;39:1390-6. [MEDLINE: 19486033]
36. Oren E, Banerji A, Clark S, Camargo CA. Food-induced anaphylaxis and repeated epinephrine treatments. Annals of Allergy Asthma and Immunology 2007;99:429-32. [MEDLINE: 18051213]
37. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clinical and Experimental Allergy 2000;30:1144-50. [MEDLINE: 10931122]
38. Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. Journal of Allergy and Clinical Immunology 2007;119:1018-9. [MEDLINE: 17349682]
39. Rawas-Qalaji MM, Simons FER, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis. Journal of Allergy and Clinical Immunology 2006;117:398-403.
40. Rawas-Qalaji M, Simons FER, Simons KJ, Collins D. Long-term stability of epinephrine dispensed in pre-filled syringes for the first-aid treatment of anaphylaxis. Annals of Allergy, Asthma, and Immunology 2009;102:500-3. [MEDLINE: 19558009]
41. The Nordic Cochrane Centre. The Cochrane Collaboration. Copenhagen: The Cochrane Collaboration, 2011.
42. Rudders SA, Banerji A, Corel B, Clark S, Camargo CA Jr. Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. Pediatrics 2010;125:e711-8. [MEDLINE: 20308215]
43. Rudders SA, Banerji A, Katzman DP, Clark S, Camargo CA Jr. Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department. Annals of Allergy, Asthma, and Immunology 2010;105:85-93. [MEDLINE: 20642208]
44. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 2006;117:391-7. [MEDLINE: 16461139]
45. Scranton SE, Gonzalez EG, Waibel KH. Incidence and characteristics of biphasic reactions after allergen immunotherapy. Journal of Allergy and Clinical Immunology 2009;123:493-8. [MEDLINE: 19064282]
46. Sheikh A, Ten Broek V, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007;62:830-7. [MEDLINE: 17620060]
47. Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD006312.pub2]
48. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. Journal of the Royal Society of Medicine 2008;101:139-43. [MEDLINE: 18344471]
49. Simons FER, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. Journal of Allergy and Clinical Immunology 1998;101:33-7. [MEDLINE: 9449498]
50. Simons FER, Gu X, Simons KJ. Outdated EpiPen and EpiPen Jr auto-injectors: past their prime?. Journal of Allergy and Clinical Immunology 2000;105:1025-30. [MEDLINE: 10808186]
51. Simons FER, Gu X, Johnston L, Simons KJ. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis?. Pediatrics 2000;106:1040-4. [MEDLINE: 11061773]
52. Simons FER, Peterson S, Black CD. Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Annals of Allergy, Asthma, and Immunology 2001;86:622-6. [MEDLINE: 11428733]
53. Simons FER, Chan ES, Gu X, Simons KJ. Epinephrine for the out-of-hospital (first aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?. Journal of Allergy and Clinical Immunology 2001;108:1040-4. [MEDLINE: 11742286]
54. Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. Journal of Allergy and Clinical Immunology 2001;108:871-3. [MEDLINE: 11692118]
55. Simons FER, Gu X, Silver NA, Simons KJ. EpiPen Jr versus EpiPen in young children weighing 15-30 kg at risk for anaphylaxis. Journal of Allergy and Clinical Immunology 2002;109:171-5. [MEDLINE: 11799385]
56. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: A novel approach to studying the epidemiology of anaphylaxis. Journal of Allergy and Clinical Immunology 2002;110:647-51. [MEDLINE: 12373275]
57. Simons FER, Sampson HA. Anaphylaxis epidemic: fact or fiction?. Journal of Allergy and Clinical Immunology 2008;122:1166-8. [MEDLINE: 19084110]
58. Simons FER. Emergency treatment of anaphylaxis. Revised UK guidelines are a concise evidence-based resource. BMJ 2008;336:1141-2. [MEDLINE: 18497373]
59. Simons FER. Anaphylaxis: recent advances in assessment and treatment. Journal of Allergy and Clinical Immunology 2009;124:625-36. [MEDLINE: 19815109]
60. Simons FER, Lieberman PL, Read EJ Jr, Edwards ES. Hazards of unintentional injection of epinephrine from auto-injectors: a systematic review. Annals of Allergy, Asthma, and Immunology 2009;102:282-7. [MEDLINE: 19441598]
61. Simons FER, Clark S, Camargo CA. Anaphylaxis in the community: learning from the survivors. Journal of Allergy and Clinical Immunology 2009;124:301-6. [MEDLINE: 19540575]
62. Simons FER, on behalf of the World Allergy Organization. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community. Annals of Allergy, Asthma, and Immunology 2009;102:403-9. [MEDLINE: 19492662]
63. Simons FER, Simons KJ. Epinephrine and its use in anaphylaxis: current issues. Current Opinion in Allergy and Clinical Immunology 2010;10:354-61. [MEDLINE: 20543673]
64. Simons FER, Edwards ES, Read EJ, Clark S, Liebelt EL. Voluntarily reported unintentional injections from epinephrine auto-injectors. Journal of Allergy and Clinical Immunology 2010b;125:419-23. [DOI: 10.1016/j.jaci.2009.10.056]
65. Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization anaphylaxis guideline: summary. Journal of Allergy and Clinical Immunology 2011;127:587-93. [MEDLINE: 21377030]
66. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 2008;77:157-69. [MEDLINE: 18358585]
67. Song TT, Nelson MR, Chang JH, Engler RJM, Chowdhury BA. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Annals of Allergy, Asthma, and Immunology 2005;94:539-42. [MEDLINE: 15945556]
68. Stecher D, Bulloch B, Sales J, Schaefer C, Keahey L. Epinephrine auto-injectors: is needle length adequate for delivery of epinephrine intramuscularly?. Pediatrics 2009;124:65-70. [MEDLINE: 19564284]
69. WHO Model List of Essential Medicines 16th edition, World Health Organization, Geneva, 2009. http://www.who.int/selection_medicines/committees/expert/17/sixteenth_adult_list_en.pdf (Accessed 15 November 2010).
70. Worth A, Soar J, Sheikh A. Management of anaphylaxis in the emergency setting. Expert Review of Clinical Immunology 2010;6:89-100. [MEDLINE: 20383894]
71. Sheikh A, Simons FER, Worth A. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD008935]